Related Experiment Videos
Near-infrared fluorescence optical imaging and tomography
Michael Gurfinkel1, Shi Ke, Xiaoxia Wen
1Department of Chemical Engineering, Texas A&M University, College Station, TX 77843-3122, USA.
Disease Markers
|April 21, 2004
Summary
This review explores near-infrared fluorescence imaging for diagnosing diseases. It highlights advances in contrast agents and imaging techniques for precise molecular targeting in tissues.
Area of Science:
- Medical imaging and spectroscopy
- Biomedical optics
- Molecular imaging
Background:
- Advances in near-infrared (NIR) laser diodes and electro-optic detection enable new diagnostic spectroscopy and imaging techniques.
- Exogenous fluorescent agents are being developed for targeted molecular imaging of diseased tissues.
Purpose of the Study:
- To review the physics, instrumentation, and advancements in near-infrared (NIR) fluorescence imaging.
- To discuss the development of NIR fluorescent contrast agents for molecular targeting.
- To evaluate the potential and limitations of fluorescence-enhanced optical imaging for deep tissue diagnostics.
Main Methods:
- Review of current research in NIR fluorescence spectroscopy and imaging.
- Discussion of advancements in tomographic reconstruction for optical imaging.
- Analysis of pharmacokinetic studies for targeted fluorescent contrast agents.
Main Results:
- Near-infrared fluorescence imaging shows promise for selective molecular targeting of diseased tissues.
- Pharmacokinetic analysis of epidermal growth factor receptor (EGFR)-targeted fluorophores in a breast cancer mouse model demonstrates specificity.
- Progress in instrumentation and contrast agent development is driving the field forward.
Conclusions:
- Near-infrared fluorescence imaging offers significant potential for molecularly targeted diagnostics.
- Further research is needed to overcome limitations for deep tissue imaging and clinical translation.
- Optimized contrast agents and advanced imaging techniques are crucial for future applications.